We concluded that hsa-miR-30a-3p significantly suppresses MMP2 and MMP9 expression and cell invasiveness in BC, which may become a potential tool of miRNA-based cancer therapy targeting MIBC. The gene discussed is MMP2; the disease is breast cancer.